Infection-related deaths from hepatitis C virus (HCV) have a high prevention rate if patients have access to direct-acting antiviral (DAA) treatments. Relaxing the eligibility criteria by widening the program across the US may reduce the health and economic burden of HCV-related mortality. References: 1. Kapadia SN, Jeng PJ, Schackman BR, Bao Y. State Medicaid hepatitis … Continue reading Relaxed Criteria for Medicaid Program Increases DAA Treatment Use in HCV